Individuals Coming Off Slimming Jabs Put On Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis reveals that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass far faster than those who end traditional lifestyle programs.

Findings released in a leading medical journal demonstrates that while overweight people can lose a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals using such medications should be cognizant of the potential of rapid weight regain when the medication ends," stated lead investigator Dr. Susan Jebb.

Such speed of regain suggests a return to pre-treatment weight within about 18 months.

Weighing Therapies

The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the effects of these new drugs with conventional dieting.

Scientists emphasize that people who shed pounds through lifestyle changes alone typically experience a more gradual creep back—perhaps 100 grams monthly—once they finish.

Understanding the Fast Rebound

Experts believe the mode of action of the jabs explains the accelerated rebound.

The injections imitate a body's own chemical called GLP-1, which controls appetite.

"Artificially providing the hormone levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement results in hunger is unsuppressed, making overeating a significant risk."

A Lifelong Disease?

The NHS suggest the jabs for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts say that, due to the likelihood of relapse, the therapy might need to be ongoing.

This opinion is echoed by pharmaceutical companies, who say that the results "highlight the chronic character of obesity," similar to managing conditions like diabetes.

User Experiences

Individuals who have discontinued the medication explain a powerful return of hunger.

"It was like a trigger that goes on and you become ravenous," described one woman.

This challenge is compounded if patients have not established permanent lifestyle or habit changes during therapy.

Widespread Interest

Figures suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand being substantial.

• Use is greater among females than men.
• The 40s and 50s age group shows the greatest level of interest.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on combined lifestyle changes.